India · Delayed Price · Currency is INR Radico Khaitan Earnings Call Transcripts
Fiscal Year 2026
-
Record revenue and EBITDA were achieved, driven by premiumization and strong brand performance. Margin expansion and robust cash flow support a positive FY 2027 outlook, with 20%-25% growth targeted in key segments and continued focus on capacity, innovation, and prudent capital allocation.
-
Record quarterly results driven by premiumization, margin expansion, and strong brand performance. Market share gains in key states, robust export growth, and a strengthened balance sheet position the company for sustained, profitable growth.
-
Q2 FY2026 saw 38% IMFL volume growth, led by premium brands and strong Andhra Pradesh gains. Gross margin held at 43.6%, EBITDA margin rose to 15.8%, and net debt fell by INR 146 crore. Double-digit growth is expected to continue, with no major CapEx planned.
-
Q1 FY26 saw record volumes, net sales, and profitability, driven by premiumization, new launches, and strong market share gains, especially in Andhra Pradesh. Margin expansion and debt reduction remain on track, with robust outlook for luxury and semi-luxury brands.
Fiscal Year 2025
-
Q4 FY25 saw record 28% volume growth and highest-ever turnover, with strong gains in premium segments and market share, especially in Andhra and UP. Margin and debt metrics improved, and new luxury launches plus FTA-driven cost savings are set to drive further growth.
-
Q3 FY25 saw 15.3% volume growth, led by strong performance in premium and luxury segments, with gross margin rising to 43%. The company expects continued momentum, margin expansion, and debt reduction, supported by robust demand and strategic brand investments.
-
Q2 FY25 saw robust growth in premium segments, with prestige and above volumes up 12.6% and EBITDA margin expanding by 250 bps year-over-year. Premiumization, innovation, and favorable regulatory changes are driving profitability, with continued margin improvement expected.
-
Premium and luxury segments drove strong value growth despite overall volume decline, with new product launches and premiumization supporting margins. Margin expansion and debt reduction remain key priorities, while regulatory and input cost risks are being managed.